Harrow, Inc. revised revenue guidance for the full year 2023. For the period, the company adjusting 2023 revenue guidance from a range of $135 million to $143 million to a range of $129 million to $136 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.49 USD | -1.79% | +1.54% | +47.23% |
May. 15 | B. Riley Raises Price Target on Harrow Health to $29 From $26, Keeps Buy Rating | MT |
May. 14 | Transcript : Harrow, Inc., Q1 2024 Earnings Call, May 14, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+47.23% | 583M | |
+37.78% | 723B | |
+31.23% | 598B | |
-3.51% | 364B | |
+19.94% | 331B | |
+5.14% | 288B | |
+15.81% | 244B | |
-4.46% | 208B | |
+9.94% | 210B | |
+9.32% | 169B |
- Stock Market
- Equities
- HROW Stock
- News Harrow, Inc.
- Harrow, Inc. Revises Revenue Guidance for the Full Year 2023